Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke
Launched by UNIVERSITY HOSPITAL, ANGERS · Jul 11, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether providing early, personalized nutrition support can help reduce the risk of death within one month after having a stroke. When someone has a stroke, they often have trouble eating enough, which can affect recovery. In this study, patients in the treatment group will be seen by a dietician within two days of their stroke. The dietician will check for any swallowing problems and work to make sure the patient gets the right amount of nutrition, either by adjusting their regular meals or, if needed, using feeding tubes or other methods. Their food intake will be closely monitored and adjusted during the first week after the stroke to meet their individual needs.
People who are 18 years or older, have had a recent stroke (within the last two days), and have a moderate to severe stroke (based on a standard stroke severity score) may be eligible. Participants need to be hospitalized for at least five days in certain specialized units and able to give consent themselves or have a family member consent for them. If accepted into the study, patients can expect regular nutrition assessments and support during their hospital stay. The study will also follow up by phone after 30 days to check on outcomes, and there will be an assessment of quality of life three months after the stroke. The goal is to see if this personalized nutrition approach can help improve survival and recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- • Patients ≥ 18 years of age
- • With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke
- • NIHSS score ≥ 5
- • Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients
- • Stroke less than 2 days old
- • Anticipated length of hospital stay in a participating centre ≥ 5 days
- • Patient affiliated to or benefiting from a social security scheme
- • Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives
- Exclusion Criteria:
- • Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.).
- • In a palliative situation where life expectancy is \< 3 months
- • Patient taking part in another study with an impact on mortality or nutrition
- • Previous inclusion in the trial
- • Pregnant, breast-feeding or parturient woman
- • Patient unable to follow the protocol for any reason
- • Patient deprived of liberty by judicial or administrative decision
- • Patient under compulsory psychiatric care
- • Person under legal protection
- • Poor understanding of the French language
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Caen, , France
Angers, , France
Toulouse, , France
La Rochelle, , France
Rouen, , France
Tours, , France
La Roche Sur Yon, , France
Cholet, , France
Le Coudray, , France
Chesnay, Yvelines, France
Saint Herblain, , France
Saint Malo, , France
Patients applied
Trial Officials
Angélique CAMPION
Principal Investigator
University Hospital, Angers
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported